OpenAI has rolled out its ChatGPT Health integration to all U.S. users over 18, allowing data syncing from Apple Health and medical record platforms. This expansion happens while the company faces a lawsuit regarding allegations of harmful medical advice provided by its AI models. OpenAI clarifies the tool is not meant for medical diagnosis.
Detailed Coverage
OpenAI has officially expanded its ChatGPT Health feature to all users aged 18 and older in the United States, regardless of their subscription status. This update allows users to link their personal health information from platforms such as Apple Health, Function, and MyFitnessPal, as well as electronic medical records from major systems including Epic and Oracle Health, directly into their chat experience.
Scaling Health Data Access
The company reported a surge in activity, with users now making approximately 300 million health-related inquiries each week. This figure marks a significant rise from the 230 million queries observed during the earlier testing phase that began in January. OpenAI has streamlined this process by allowing users to integrate their health data directly into standard conversations, moving away from the previous requirement to use a specific, isolated hub for medical inquiries. Data from the company indicates that about 70% of health-related interactions were already occurring outside of that dedicated section, prompting this integration.
Model Benchmarks and Safety Measures
In terms of technical performance, OpenAI states its newest model, GPT-5.6-Luna, has shown higher accuracy scores on the HealthBench internal evaluation compared to the previous GPT-5.5 version. Despite these improvements, the company continues to include strict disclaimers in its terms of service, noting that ChatGPT is not a medical professional and should not be used for diagnosis or treatment. This stance has become a focal point in recent litigation, where a Florida-based complainant alleged that the AI provided dangerous medical suggestions. OpenAI has publicly stated that it works with medical professionals to improve the safety of its responses and confirms that user data linked through this feature is not utilized to train its future models.
Regulatory and Practical Risks
For investors and users alike, the legal and regulatory environment remains a key monitorable. As AI companies move deeper into specialized sectors like healthcare, they face increased scrutiny over liability and the accuracy of automated advice. The ongoing lawsuit serves as a reminder of the potential for reputational and legal risks when AI tools are applied to high-stakes fields. Moving forward, the effectiveness of OpenAI’s safety protocols, the outcome of current litigation, and the company's ability to maintain public trust regarding data privacy will be essential factors in determining the long-term viability of its health-related services.